Key Takeaways
Teleflex Incorporated (NYSE: TFX) reported first-quarter adjusted earnings of $1.39 per share, surpassing analyst estimates of $1.21, even as the company navigates a significant strategic transformation through major divestitures.
"Our first-quarter performance reflects disciplined execution and meaningful progress against our transformation plan," Stuart Randle, Teleflex's Interim President and Chief Executive Officer, said. "We delivered a strong start to the year, with 5.1% pro forma adjusted constant currency revenue growth year-over-year."
The medical technology company posted revenue from continuing operations of $548.3 million, a 32.3 percent increase from the same period last year and ahead of consensus estimates. The results were driven by strong performance across its global product categories, with the Interventional segment reporting 104.4 percent revenue growth. However, the company recorded a GAAP diluted loss of $(0.11) per share from continuing operations, compared to a $1.14 profit in the prior year, reflecting costs associated with its restructuring.
Despite the GAAP loss, Teleflex affirmed its full-year 2026 guidance, projecting adjusted diluted earnings per share between $6.25 and $6.55 and GAAP revenue growth between 14.40 percent and 15.40 percent. This outlook excludes the expected benefits from agreements tied to its strategic divestitures, which the company anticipates will offset associated stranded costs.
The company's transformation includes agreements to divest its Acute Care, Interventional Urology, and OEM businesses, which are classified as discontinued operations. Teleflex expects these two strategic divestitures to close in the second half of 2026. Mr. Randle confirmed the company remains committed to using the majority of net proceeds to return capital to shareholders via a $1 billion share repurchase program and to pay down approximately $800 million in debt.
The guidance maintenance suggests management's confidence that core business performance can support its outlook through a period of significant change. Investors will be watching for the successful closing of the two strategic divestitures in the second half of 2026, which will be the next major step in the company's plan to streamline its portfolio.
This article is for informational purposes only and does not constitute investment advice.
